tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Akash Tewari, 165 are a BUY (79.71%), 36 are a HOLD (17.39%), 6 are a SELL (2.9%).
Analyst Akash Tewari, currently employed at JEFFERIES, carries an average stock price target met ratio of 59.16% that have a potential upside of 37.56% achieved within 255 days. Previously, Akash Tewari worked at WOLFE.
Akash Tewari’s has documented 407 price targets and ratings displayed on 38 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on REGN, Regeneron Pharmaceuticals at 01-Oct-2026.
Analyst best performing recommendations are on ARVN (ARVINAS).
The best stock recommendation documented was for ARVN (ARVINAS) at 6/21/2022. The price target of $42 was fulfilled within 2 days with a profit of $3.11 (8%) receiving and performance score of 39.98.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 15-Oct-2026
$55
$13.78 (33.43%)
$21
6 days ago
(15-Oct-2026)
7/8 (87.5%)
$13.78 (33.43%)
880
Hold Since 23-Sep-2026
$50
$8.78 (21.30%)
$43
28 days ago
(23-Sep-2026)
1/2 (50%)
$9.21 (22.58%)
324
Buy Since 07-Oct-2025
$56
$14.78 (35.86%)
$56
1 months ago
(21-Sep-2026)
8/10 (80%)
$12.71 (29.36%)
304
Buy Since 17-Mar-2024
$61
$19.78 (47.99%)
$58
1 months ago
(21-Sep-2026)
6/8 (75%)
$17.71 (40.91%)
450
Buy Since 27-May-2025
$62
$20.78 (50.41%)
$62
1 months 1 days ago
(20-Sep-2026)
6/9 (66.67%)
$17.82 (40.33%)
223
Which stock is Akash Tewari most bullish on?
Which stock is Akash Tewari most reserved on?
What Year was the first public recommendation made by Akash Tewari?
